Richard Hufton

1.4k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Richard Hufton is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Richard Hufton has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Richard Hufton's work include Asymmetric Synthesis and Catalysis (5 papers), Coordination Chemistry and Organometallics (5 papers) and Advanced Synthetic Organic Chemistry (3 papers). Richard Hufton is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Coordination Chemistry and Organometallics (5 papers) and Advanced Synthetic Organic Chemistry (3 papers). Richard Hufton collaborates with scholars based in United Kingdom, Australia and Sweden. Richard Hufton's co-authors include Iain Coldham, David J. Snowden, J. Stephen Clark, Olivier Hamelin, David J. Owen, G. P. Vennall, Charles S. Elmore, Marianne Ashford, Robert De Rose and Angus P. R. Johnston and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and ACS Nano.

In The Last Decade

Richard Hufton

12 papers receiving 1.1k citations

Hit Papers

Intramolecular Dipolar Cycloaddition Reactions of Azometh... 2005 2026 2012 2019 2005 250 500 750

Peers

Richard Hufton
Ian F. Cottrell United Kingdom
Andrew G. Lohse United States
Joseph J. Badillo United States
Clive S. Penkett United Kingdom
Conrad J. Kowalski United Kingdom
Cameron J. Cowden United Kingdom
Ian F. Cottrell United Kingdom
Richard Hufton
Citations per year, relative to Richard Hufton Richard Hufton (= 1×) peers Ian F. Cottrell

Countries citing papers authored by Richard Hufton

Since Specialization
Citations

This map shows the geographic impact of Richard Hufton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hufton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hufton more than expected).

Fields of papers citing papers by Richard Hufton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Hufton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hufton. The network helps show where Richard Hufton may publish in the future.

Co-authorship network of co-authors of Richard Hufton

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hufton. A scholar is included among the top collaborators of Richard Hufton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hufton. Richard Hufton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yuen, Daniel, Orlagh M. Feeney, Victoria M. McLeod, et al.. (2025). Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration. ACS Nano. 19(6). 6044–6057. 3 indexed citations
2.
Feeney, Orlagh M., Ka Fung Noi, Dharmini Mehta, et al.. (2022). Subcutaneous delivery of a dendrimer-BH3 mimetic improves lymphatic uptake and survival in lymphoma. Journal of Controlled Release. 348. 420–430. 10 indexed citations
3.
Kelly, Brian D., Victoria M. McLeod, Susan Jackson, et al.. (2020). Abstract 1716: Anticancer activity of the taxane nanoparticles, DEP® docetaxel and DEP® cabazitaxel. Cancer Research. 80(16_Supplement). 1716–1716. 10 indexed citations
4.
Kelly, Brian D., Victoria M. McLeod, Susan Jackson, et al.. (2020). Abstract 1715: Anti-cancer activity of a SN-38 nanoparticle, DEP® irinotecan, in human colon cancer xenograft models. Cancer Research. 80(16_Supplement). 1715–1715. 2 indexed citations
5.
Coldham, Iain & Richard Hufton. (2005). Intramolecular Dipolar Cycloaddition Reactions of Azomethine Ylides. Chemical Reviews. 105(7). 2765–2810. 921 indexed citations breakdown →
6.
Coldham, Iain & Richard Hufton. (2005). Intramolecular Dipolar Cycloaddition Reactions of Azomethine Ylides. ChemInform. 36(42). 1 indexed citations
7.
Coldham, Iain, et al.. (2002). Stereoselective Synthesis of Pyrrolidines and Pyrrolizidines by Intramolecular Carbolithiation. Synthesis. 2001(10). 9 indexed citations
8.
Clark, J. Stephen, Olivier Hamelin, & Richard Hufton. (1998). Synthesis of medium-sized cyclic allylic ethers by ring-closing metathesis and subsequent elaboration to sub-units found in the brevetoxins and ciguatoxins. Tetrahedron Letters. 39(45). 8321–8324. 30 indexed citations
9.
Coldham, Iain, et al.. (1997). Stereoselective Anionic Cyclizations to Pyrrolidines. Tetrahedron Letters. 38(43). 7617–7620. 15 indexed citations
10.
Coldham, Iain, Richard Hufton, & David J. Snowden. (1996). Anionic Cyclizations of α-Aminoorganolithiums. Determination of the Stereoselectivity at the Carbanion Center and the Synthesis of (+)-Pseudoheliotridane. Journal of the American Chemical Society. 118(22). 5322–5323. 83 indexed citations
11.
Coldham, Iain & Richard Hufton. (1996). Synthesis of 3-alkylpyrrolidines by anionic cyclization. Tetrahedron. 52(38). 12541–12552. 26 indexed citations
12.
Coldham, Iain & Richard Hufton. (1995). A new route to cyclic amines by anionic cyclization. Tetrahedron Letters. 36(12). 2157–2160. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026